These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31844967)

  • 1. The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Yari Z; Movahedian M; Imani H; Alavian SM; Hedayati M; Hekmatdoost A
    Eur J Nutr; 2020 Sep; 59(6):2569-2577. PubMed ID: 31844967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flaxseed and/or hesperidin supplementation in metabolic syndrome: an open-labeled randomized controlled trial.
    Yari Z; Cheraghpour M; Hekmatdoost A
    Eur J Nutr; 2021 Feb; 60(1):287-298. PubMed ID: 32296931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Hesperidin and Diosmin Individually or in Combination on Metabolic Profile and Neuropathy among Diabetic Patients with Metabolic Syndrome: A Randomized Controlled Trial.
    Osama H; Hamed EO; Mahmoud MA; Abdelrahim MEA
    J Diet Suppl; 2023; 20(5):749-762. PubMed ID: 35946912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial.
    Kjær TN; Ornstrup MJ; Poulsen MM; Stødkilde-Jørgensen H; Jessen N; Jørgensen JOL; Richelsen B; Pedersen SB
    J Clin Endocrinol Metab; 2017 May; 102(5):1642-1651. PubMed ID: 28182820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Insulin Resistance and Oxidative Stress in a Mouse Model of Metabolic Syndrome following Twelve Weeks of Citrus Bioflavonoid Hesperidin Supplementation: A Dose-Response Study.
    Jamal A; Brettle H; Jamil DA; Tran V; Diep H; Bobik A; van der Poel C; Vinh A; Drummond GR; Thomas CJ; Jelinic M; Al-Aubaidy HA
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sesame oil and vitamin E co-administration may improve cardiometabolic risk factors in patients with metabolic syndrome: a randomized clinical trial.
    Farajbakhsh A; Mazloomi SM; Mazidi M; Rezaie P; Akbarzadeh M; Ahmad SP; Ferns GA; Ofori-Asenso R; Babajafari S
    Eur J Clin Nutr; 2019 Oct; 73(10):1403-1411. PubMed ID: 31089253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Rodríguez-Morán M; Simental-Mendía LE; Gamboa-Gómez CI; Guerrero-Romero F
    Adv Chronic Kidney Dis; 2018 May; 25(3):261-266. PubMed ID: 29793665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthocyanins in berries exhibited anti-atherogenicity and antiplatelet activities in a metabolic syndrome population.
    Aboonabi A; Meyer RR; Gaiz A; Singh I
    Nutr Res; 2020 Apr; 76():82-93. PubMed ID: 32217379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple-Blind, Placebo-Controlled Trial.
    Rahimi F; Pasdar Y; Kaviani M; Abbasi S; Fry H; Hekmatdoost A; Nikpayam O; Sohrab G; Rezaei M; Nachvak SM; Mohammadi R
    Int J Clin Pract; 2022; 2022():2967977. PubMed ID: 35685524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Selenium Supplementation on Metabolic Status in Patients Undergoing for Coronary Artery Bypass Grafting (CABG) Surgery: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Kamali A; Amirani E; Asemi Z
    Biol Trace Elem Res; 2019 Oct; 191(2):331-337. PubMed ID: 30637662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double-blind clinical trial.
    Bateni Z; Rahimi HR; Hedayati M; Afsharian S; Goudarzi R; Sohrab G
    Phytother Res; 2021 Jul; 35(7):3945-3953. PubMed ID: 33851448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial.
    Raygan F; Ostadmohammadi V; Bahmani F; Reiter RJ; Asemi Z
    Clin Nutr; 2019 Feb; 38(1):191-196. PubMed ID: 29275919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Folic Acid Supplementation on Recurrence and Metabolic Status in Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Bahmani F; Rahimi Galougahi F; Vahedpoor Z; Jamilian M; Mahmoodi S; Baghban R; Bagherian T; Zarezade Mehrizi M; Asemi Z
    Arch Iran Med; 2018 Oct; 21(10):452-459. PubMed ID: 30415553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Pomegranate Juice on Cardiovascular Risk Factors in Patients with Metabolic Syndrome: a Double-Blinded, Randomized Crossover Controlled Trial.
    Moazzen H; Alizadeh M
    Plant Foods Hum Nutr; 2017 Jun; 72(2):126-133. PubMed ID: 28303364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial.
    Sohaei S; Amani R; Tarrahi MJ; Ghasemi-Tehrani H
    Complement Ther Med; 2019 Dec; 47():102201. PubMed ID: 31780025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementation with Low Doses of a Cod Protein Hydrolysate on Glucose Regulation and Lipid Metabolism in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study.
    Jensen C; Fjeldheim Dale H; Hausken T; Hatlebakk JG; Brønstad I; Lied GA; Hoff DAL
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. δ-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial.
    Fatima S; Khan DA; Aamir M; Pervez MA; Fatima F
    Metab Syndr Relat Disord; 2023 Feb; 21(1):25-34. PubMed ID: 36125447
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.